Treatment of vitiligo vulgaris with narrow-band UVB and oral polypodium leucotomos extract: A randomized double-blind placebo-controlled study Journal Article


Authors: Middelkamp-Hup, M. A.; Bos, J. D.; Rius-Diaz, F.; Gonzalez, S.; Westerhof, W.
Article Title: Treatment of vitiligo vulgaris with narrow-band UVB and oral polypodium leucotomos extract: A randomized double-blind placebo-controlled study
Abstract: Background: The first choice treatment for vitiligo vulgaris is narrow-band UVB (NB-UVB), but no satisfactory treatment exists. Objectives: To investigate if Polypodium leucotomos , an antioxidative and immunomodulatory plant extract, improves NB-UVB-induced repigmentation. Methods: Fifty patients with vitiligo vulgaris randomly received 250 mg oral P. leucotomos or placebo three times daily, combined with NB-UVB twice weekly for 25-26 weeks. Results: Repigmentation was higher in the P. leucotomos group vs. placebo in the head and neck area (44% vs. 27%, P = 0.06). Small repigmentation increases (P = n.s.) were observed for the trunk (6% increased repigmentation), extremities (4%), and hands and feet (5%) in the P. leucotomos group vs. placebo. Patients attending more than 80% of required NB-UVB sessions showed increased repigmentation in the head and neck area in the P. leucotomos group vs. placebo (50% vs. 19%, P < 0.002); no significant differences were seen in the other body areas. Patients with skin types 2 and 3 showed more repigmentation in the head and neck area in the P. leucotomos group vs. placebo (47% vs. 21%, P = 0.01), and no significant differences were seen in the other body areas. No conclusions could be drawn on skin types 4 and 5 due to low patient numbers. Conclusion: There is a clear trend towards an increase in repigmentation of vitiligo vulgaris affecting the head and neck area when NB-UVB phototherapy is combined with oral P. leucotomos. This effect may be more pronounced in light skin types. © 2007 The AuthorsJournal compilation © 2007 European Academy of Dermatology and Venereology.
Keywords: adult; controlled study; treatment outcome; aged; middle aged; major clinical study; clinical trial; placebo; combined modality therapy; prospective studies; quality of life; controlled clinical trial; skin pigmentation; randomized controlled trial; interleukin 10; disease severity; severity of illness index; tumor necrosis factor alpha; gamma interferon; limb; blood analysis; scoring system; interleukin 6; cytokine production; immunomodulation; neck; plant extract; phytotherapy; plant extracts; antioxidant; ultraviolet b radiation; double blind procedure; double-blind method; administration, oral; statistics, nonparametric; polypodium leucotomos extract; polypodium; herbal medicine; foot; hand; head; polypodium leucotomos; vitiligo; skin color; trunk; phototherapy; narrow-band uvb; vitiligo vulgaris; ultraviolet therapy
Journal Title: Journal of the European Academy of Dermatology and Venereology
Volume: 21
Issue: 7
ISSN: 0926-9959
Publisher: Wiley Blackwell  
Date Published: 2007-08-01
Start Page: 942
End Page: 950
Language: English
DOI: 10.1111/j.1468-3083.2006.02132.x
PUBMED: 17659004
PROVIDER: scopus
DOI/URL:
Notes: --- - "Cited By (since 1996): 18" - "Export Date: 17 November 2011" - "CODEN: JEAVE" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Salvador Gonzalez Rodriguez
    203 Rodriguez